SUSTAINED RELEASE COMPOSITIONS OF 4-AMINOPYRIDINE

The present invention generally relates to sustained release 4-aminopyridine tablets, which include a core and a coating. The sustained release tablets of the invention are generally suitable for once daily oral administration for the treatment of neurological disorders.

Saved in:
Bibliographic Details
Main Authors Way, Susan L, Cobb, JR., Joseph E, D'Souza, Rohini, Gold, Thomas B
Format Patent
LanguageEnglish
Published 04.11.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention generally relates to sustained release 4-aminopyridine tablets, which include a core and a coating. The sustained release tablets of the invention are generally suitable for once daily oral administration for the treatment of neurological disorders.
Bibliography:Application Number: US202117374285